Chicago Equity Partners’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-33,570	Closed	-$521K	–	894
2019 Q3	$521K	Buy	33,570 +10,360	+45%	+$161K	0.02%	674
2019 Q2	$471K	Buy	+23,210	New	+$471K	0.02%	714